Sentences with phrase «longest median survival»

Dogs in the standard - dose and low - dose pimobendan groups had significantly longer median survival times than dogs in the conventional group (334, 277 and 136 days, respectively; P < 0.001).

Not exact matches

«Patients who respond to immunotherapy tend to continue their responses for long durations, and these lengthier responses are cut off in calculations of median overall survival,» she says.

In examining the STS - CMS linked data, researchers found that the median survival following lung cancer surgery for pathologic Stage I (early stage) was 6.7 years, almost 2 years longer than the benchmark 5 - year survival rate.

Patients treated with precision medicine also benefited from longer progression - free survival with a median of 5.7 months before their disease worsened compared to 2.95 months for the others.

But for the hundred or so cougars living in the rugged Santa Cruz mountains, the four - lane thoroughfare, divided in places by tall medians, is a formidable barrier that threatens their long - term survival.

The team found that patients with more varied types of bacteria in their digestive tract had longer median progression - free survival, defined at the time point where half of studied patients have their disease progress.

Appearing in Lancet Oncology, long term results of EORTC trial 22921 with 10.4 years median follow - up show that 5 - FU (fluorouracil) based adjuvant chemotherapy after preoperative (chemo)- radiotherapy for patients with cT3 - resectable T4 M0 rectal cancer does not improve survival or disease - free survival.

In a study presented today at a meeting of women's cancer specialists, overall survival for women who received standard chemotherapy treatment plus bevacizumab was a median five months longer than for women who received the standard chemotherapy treatment alone.

Most importantly, patients who were negative for PD - L1 expression survived around 11 months longer than patients who were positive for PD - L1 expression (median survival 4.79 vs 16.3 months).

Some patients given both treatments lived significantly longer (years) than expected, while the overall median survival increased by 59 % (2.6 months).

Women with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone, according to a study published conducted by the Gynecologic Oncology Group (GOG), a National Cancer Institute - supported research network, in the January 5, 2006 issue of the New England Journal of Medicine.

The treatment resulted in a median overall survival (OS) of longer than 3 years in both arms of the trial (median OS, 38.2 months for irradiation vs 36.6 months for nonmyeloablating chemotherapy alone; hazard ratio, 1.11 [95 % CI, 0.65 — 1.91]-RRB-.

Encouragingly, this anti-tumor effect converted into a pro-survival effect also, as the authors noted an improvement in the median survival of mice treated with the long - term expanded iPSC - NKs or PB - NKs from 73 days to 98 and 97 days, respectively (See adjoined figure).

Quality of life was significantly higher in participants randomized to the intervention group, who demonstrated a statistically and clinically meaningful increase in QOL at 12 weeks (P <.05 using the nonparametric Wilcoxon test).31, 32 Median survival was almost 5 months longer in the intervention group.

In the trial, patients who received Rydapt in combination with chemotherapy lived longer than patients who received chemotherapy alone, although a specific median survival rate could not be reliably estimated.

While the duration of response in the velimogene aliplasmid responders was marginally longer than with DTIC / TMZ (P =.066), overall survival was shorter (median, 18.8 months [95 % CI, 16.6 — 21.3 months] vs 24.1 months [95 % CI, 17.1 — 27.9 months]; P =.491).

This translated into a median survival of 10.4 years for females with more than 4.5 years of ovary exposure — 1.4 years longer than the median survival of only 9.0 years in females with shorter ovary exposure (p < 0.0001).

Cats treated with a multidrug chemotherapy protocol have a median survival time of 7 months; however some cats that achieve complete remission can live longer.

«Prior to this, the longest reported median survival time of dogs with hemangiosarcoma of the spleen that underwent no further treatment was 86 days.

Dogs in the SPAY 1 group lived significantly longer than dogs in SPAY 2 and intact dogs (median survival of 755 days, versus 301 and 286 days, respectively, P =.02 and.03).